Neurological Implants Market is projected to reach US$ 12.39 billion by 2031 | NeuroPace Inc, Aleva Neurotherapeutics, Renishaw PLC, NEVRO CORP, Synapse Biomedical Inc, LivaNova PLC.

The global neurological implants market was valued at approximately US$ 5.88 billion in 2023 and is projected to reach around US$ 12.39 billion by 2031, expanding at a compound annual growth rate (CAGR) of 9.8% during the forecast period from 2024 to 2031.

The Neurological Implants Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/neurological-implants-market?sg

Neurological Implants Market Overview:

Neurological implants are advanced medical devices surgically implanted into the brain or nervous system to treat a wide range of neurological conditions. These devices are designed to modulate neural activity, either by delivering electrical stimulation or by recording brain signals for therapeutic or research purposes.

One prominent application is deep brain stimulation (DBS), where electrodes deliver controlled electrical pulses to targeted brain regions. This technique is commonly used to manage symptoms in conditions like Parkinson's disease, epilepsy, and chronic pain, providing significant relief where medications may fall short.

Neurological implants also play a vital role in restoring function for individuals with severe disabilities. Through brain-computer interfaces (BCIs), neural signals can be translated into digital commands, enabling users to control prosthetic limbs, computers, or other external systems purely by thought. This technology is paving the way for greater independence and improved quality of life in patients with motor impairments.

In research, these implants offer a window into brain function, allowing scientists to observe and analyze neural activity in real time. Such insights are critical for developing new therapies and understanding the progression of neurological diseases.

Typically, neurological implants consist of electrodes positioned in specific areas of the brain and a processing unit that interprets or modulates the signals. Depending on their purpose, they may stimulate brain tissue or capture neural data for analysis. The growing demand for innovative treatment options and the rapid advancement in neurotechnology are major factors propelling the global neurological implants market forward.

Neurological Implants Industry Trends:

Growing Prevalence of Neurological Disorders

The increasing global burden of neurological conditions is a key factor fueling the expansion of the neurological implants market, and this trend is expected to continue throughout the forecast period.

Disorders such as Parkinson's disease, Alzheimer's, epilepsy, and chronic pain syndromes are affecting a rapidly growing segment of the population. With millions of individuals impacted, the demand for advanced medical interventions like neurological implants that offer symptom relief and improve quality of life continues to rise.

A landmark study published in The Lancet Neurology, conducted in collaboration with the World Health Organization (WHO) as part of the Global Burden of Disease (GBD) 2021 analysis, revealed that over 3 billion people worldwide were living with a neurological disorder as of 2021. These conditions now represent the leading cause of disability and health loss globally.

The study also highlighted an 18% increase in disability-adjusted life years (DALYs) due to neurological disorders since 1990, underscoring their growing impact on public health.

Alarmingly, more than 80% of deaths and disabilities linked to neurological disorders occur in low- and middle-income countries, where access to treatment remains severely limited. For instance, high-income nations have up to 70 times more neurological healthcare professionals per 100,000 people compared to resource-constrained regions, exposing a major gap in neurological care delivery.

This growing disease burden, combined with disparities in access to care, is accelerating the adoption of neurological implants as a crucial therapeutic solution, particularly in efforts to manage and mitigate symptoms where traditional treatments may fall short.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/neurological-implants-market?sg

Strategic Players Driving the Neurological Implants Market: Medtronic, Boston Scientific Corporation, NeuroPace Inc., Abbott Laboratories, Aleva Neurotherapeutics, Renishaw PLC, NEVRO CORP., Synapse Biomedical Inc., and LivaNova PLC.

Research Methodology:

The global Neurological Implants Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Neurological Implants Market:

By Product Type (Deep Brain Stimulators, Vagus Nerve Stimulators, Spinal Cord Stimulators)

By Material (Silicon, Tungsten, Platinum-iridium, Nanotubes, Others)

By Application (Chronic Pain, Parkinson's Disease, Epilepsy, Depression, Essential Tremor, Alzheimer's Disease)

By End-User (Hospitals, Neurology Clinics, Others)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Industry Recent Developments:

✅ Globus Medical Completes Acquisition of Nevro:

Globus Medical finalized a ~$250 million all-cash acquisition of Nevro Corp. a leader in high-frequency spinal cord stimulation (SCS) technology. Nevro's 10 kHz HFXTM Senza® system and related services now bolster Globus's neuromodulation and musculoskeletal portfolio, targeting the $2.5 billion chronic pain market. Post-closing, Globus plans to leverage its global distribution and infrastructure to accelerate commercial reach and earnings growth in the neuromodulation space.

✅ Sanofi Agrees to Acquire Vigil Neuroscience

Sanofi entered a definitive agreement to acquire Vigil Neuroscience for $8/share upfront (~$470 million), plus a $2/share contingent value right (CVR), bringing total deal value to up to ~$600 million. The acquisition centers on Vigil's oral TREM2 agonist, VG‐3927, now in Phase II for Alzheimer's disease. Sanofi expects to close the deal in Q3 2025, strengthening its neurology pipeline without altering its 2025 forecast.

Regional Analysis for Neurological Implants Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Neurological Implants Market Research Industry:

➠ Who leads the Neurological Implants industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Neurological Implants market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Neurological Implants market growth?

➠ What are the dominant sales and distribution strategies in the Neurological Implants industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.